-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Panacea Life Sciences Holdings, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2021 to 2023.
- Panacea Life Sciences Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2024 was $1.06M, a 55.9% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2024 was $2.76M, a 50.4% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $2.38M, a 46.6% increase from 2022.
- Panacea Life Sciences Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $1.63M, a 21% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)